MedicaidSeptember 1, 2023
Consider a FIT kit for patients at average risk for colon cancer
Beginning January 1, 2024, Empire became Anthem. This article, published under the former brand, now applies to Anthem.
The American Cancer Society (ACS) recommends annual fecal immunochemical test (FIT) kit testing for all adults aged 45 and older with average risk for colon cancer. For these patients, the FIT kit is a convenient, cost effective, and discreet testing option.1, 2
FIT kits offer a cost effective, highly accurate option for colorectal cancer screening
Screening with FIT kits is convenient and easier than ever. Adopting FIT screening into your practice can help increase patient adherence to colon cancer screening recommendations. Annual FIT improves screening rates and has also been shown to save lives.3
Empire BlueCross BlueShield HealthPlus physicians and their patients have access to high-quality, low-cost colorectal cancer screening FIT kits through our National Lab partners Labcorp* and Quest Diagnostics*. If you have specific questions, please contact the labs directly:
Labcorp: ColoFIT™, 855-LABCORP (855-522-2677), labcorp.com; labcorp.com/cancer/colorectal/providers:
- Quest Diagnostics: InSure® ONE™ kit, 866-MY-QUEST (866-697-8378) or QuestInSureONE.com
To find Labcorp, Quest Diagnostics, and other participating labs in your patient’s plan network, select Find Care from the Provider Resources menu at anthem.com.
References:
1. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.CA Cancer J Clin.2018;68(4):250-281.
2. Occult blood, fecal, immunoassay. Laboratory Corporation of America Holdings and Lexi-Comp Inc. 2021. Accessed April 11, 2022.https://www.labcorp.com/tests/182949/occult-blood-fecal-immunoassay.
3. Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis.JAMA Intern Med.2018;178(12):1645-1658.
*Labcorp is an independent company providing lab services on behalf of the health plan. Quest Diagnostics is an independent company providing lab services on behalf of the health plan.
NYBCBS-CD-034186-23
PUBLICATIONS: September 2023 Provider Newsletter
To view this article online:
Or scan this QR code with your phone